Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Genomic characterization of Ralstonia solanacearum phage ϕRS138 of the family Siphoviridae.

Van Truong Thi B, Pham Khanh NH, Namikawa R, Miki K, Kondo A, Dang Thi PT, Kamei K.

Arch Virol. 2016 Feb;161(2):483-6. doi: 10.1007/s00705-015-2654-1. Epub 2015 Nov 3.

PMID:
26526151
2.

Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models.

Duramad O, Laysang A, Li J, Ishii Y, Namikawa R.

Biol Blood Marrow Transplant. 2011 Aug;17(8):1154-68. doi: 10.1016/j.bbmt.2010.11.022. Epub 2010 Dec 8.

3.

Disparate regulation of human fetal erythropoiesis by the microenvironments of the liver and bone marrow.

Muench MO, Namikawa R.

Blood Cells Mol Dis. 2001 Mar-Apr;27(2):377-90.

PMID:
11259159
4.

Generation of primary antigen-specific human T- and B-cell responses in immunocompetent SCID-hu mice.

Carballido JM, Namikawa R, Carballido-Perrig N, Antonenko S, Roncarolo MG, de Vries JE.

Nat Med. 2000 Jan;6(1):103-6. No abstract available.

PMID:
10613834
5.

Administration of Flk2/Flt3 ligand induces expansion of human high-proliferative potential colony-forming cells in the SCID-hu mouse.

Namikawa R, Muench MO, Firpo MT, Humeau L, Xu Y, Menon S, Roncarolo MG.

Exp Hematol. 1999 Jun;27(6):1029-37.

PMID:
10378892
6.

SCID-hu mice for the study of human cancer metastasis.

Namikawa R, Shtivelman E.

Cancer Chemother Pharmacol. 1999;43 Suppl:S37-41.

PMID:
10357557
7.

Ex vivo manipulations alter the reconstitution potential of mobilized human CD34+ peripheral blood progenitors.

Humeau L, Namikawa R, Bardin F, Mannoni P, Roncarolo MG, Chabannon C.

Leukemia. 1999 Mar;13(3):438-52.

8.

Furry flasks?

Namikawa R, Kaneshima H, McCune JM.

Nat Biotechnol. 1998 Apr;16(4):314. No abstract available.

PMID:
9555715
9.

Successful reconstitution of human hematopoiesis in the SCID-hu mouse by genetically modified, highly enriched progenitors isolated from fetal liver.

Humeau L, Chabannon C, Firpo MT, Mannoni P, Bagnis C, Roncarolo MG, Namikawa R.

Blood. 1997 Nov 1;90(9):3496-506.

PMID:
9345033
11.
12.

Antigen-specific cytotoxic T cells mediate human fetal pancreas allograft rejection in SCID-hu mice.

Rouleau M, Namikawa R, Antonenko S, Carballido-Perrig N, Roncarolo MG.

J Immunol. 1996 Dec 15;157(12):5710-20.

PMID:
8955225
13.

Human T-and B-cell functions in SCID-hu mice.

Roncarolo MG, Carballido JM, Rouleau M, Namikawa R, de Vries JE.

Semin Immunol. 1996 Aug;8(4):207-13. Review.

PMID:
8883143
14.

Regulatory roles of the ligand for Flk2/Flt3 tyrosine kinase receptor on human hematopoiesis.

Namikawa R, Muench MO, Roncarolo MG.

Stem Cells. 1996 Jul;14(4):388-95. Review.

15.
16.

IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist.

Carballido JM, Schols D, Namikawa R, Zurawski S, Zurawski G, Roncarolo MG, de Vries JE.

J Immunol. 1995 Nov 1;155(9):4162-70.

PMID:
7594571
17.
18.

FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver.

Muench MO, Roncarolo MG, Menon S, Xu Y, Kastelein R, Zurawski S, Hannum CH, Culpepper J, Lee F, Namikawa R.

Blood. 1995 Feb 15;85(4):963-72.

PMID:
7531516
19.

Progress in the ex vivo expansion of hematopoietic progenitors.

Muench MO, Roncarolo MG, Namikawa R, Bárcena A, Moore MA.

Leuk Lymphoma. 1994 Dec;16(1-2):1-11. Review.

PMID:
7696914
20.

Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice.

Chen BP, Galy A, Kyoizumi S, Namikawa R, Scarborough J, Webb S, Ford B, Cen DZ, Chen SC.

Blood. 1994 Oct 15;84(8):2497-505.

PMID:
7522631
21.

Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34.

DiGiusto D, Chen S, Combs J, Webb S, Namikawa R, Tsukamoto A, Chen BP, Galy AH.

Blood. 1994 Jul 15;84(2):421-32.

PMID:
7517715
22.

Human hematolymphoid cells in SCID mice.

Kaneshima H, Namikawa R, McCune JM.

Curr Opin Immunol. 1994 Apr;6(2):327-33. Review.

PMID:
7912081
23.

Direct evaluation of radiation damage in human hematopoietic progenitor cells in vivo.

Kyoizumi S, McCune JM, Namikawa R.

Radiat Res. 1994 Jan;137(1):76-83.

PMID:
7505456
24.

Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice.

Namikawa R, Ueda R, Kyoizumi S.

Blood. 1993 Oct 15;82(8):2526-36.

PMID:
8104540
25.

Preclinical analysis of cytokine therapy in the SCID-hu mouse.

Kyoizumi S, Murray LJ, Namikawa R.

Blood. 1993 Mar 15;81(6):1479-88.

PMID:
7680919
26.

Implantation and maintenance of functional human bone marrow in SCID-hu mice.

Kyoizumi S, Baum CM, Kaneshima H, McCune JM, Yee EJ, Namikawa R.

Blood. 1992 Apr 1;79(7):1704-11.

PMID:
1558966
27.

Human hematopoietic cells and thymic epithelial cells induce tolerance via different mechanisms in the SCID-hu mouse thymus.

Vandekerckhove BA, Namikawa R, Bacchetta R, Roncarolo MG.

J Exp Med. 1992 Apr 1;175(4):1033-43.

28.

Human T cells in the SCID-hu mouse are phenotypically normal and functionally competent.

Krowka JF, Sarin S, Namikawa R, McCune JM, Kaneshima H.

J Immunol. 1991 Jun 1;146(11):3751-6.

PMID:
1827814
29.

Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse.

Kaneshima H, Shih CC, Namikawa R, Rabin L, Outzen H, Machado SG, McCune JM.

Proc Natl Acad Sci U S A. 1991 May 15;88(10):4523-7.

30.

Granzyme A and perforin as markers for rejection in cardiac transplantation.

Griffiths GM, Namikawa R, Mueller C, Liu CC, Young JD, Billingham M, Weissman I.

Eur J Immunol. 1991 Mar;21(3):687-93.

PMID:
2009911
31.

Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner.

Shih CC, Kaneshima H, Rabin L, Namikawa R, Sager P, McGowan J, McCune JM.

J Infect Dis. 1991 Mar;163(3):625-7.

PMID:
1995734
32.

The SCID-hu mouse: a small animal model for HIV infection and pathogenesis.

McCune J, Kaneshima H, Krowka J, Namikawa R, Outzen H, Peault B, Rabin L, Shih CC, Yee E, Lieberman M, et al.

Annu Rev Immunol. 1991;9:399-429. Review.

PMID:
1910684
33.

Today's SCID-hu mouse.

Kaneshima H, Baum C, Chen B, Namikawa R, Outzen H, Rabin L, Tsukamoto A, McCune JM.

Nature. 1990 Dec 6;348(6301):561-2. No abstract available.

PMID:
2247165
34.

Pseudotypes in HIV-infected mice.

McCune JM, Namikawa R, Shih CC, Rabin L, Kaneshima H.

Science. 1990 Nov 23;250(4984):1152-4. No abstract available.

PMID:
2174574
35.

Long-term human hematopoiesis in the SCID-hu mouse.

Namikawa R, Weilbaecher KN, Kaneshima H, Yee EJ, McCune JM.

J Exp Med. 1990 Oct 1;172(4):1055-63.

36.

Suppression of HIV infection in AZT-treated SCID-hu mice.

McCune JM, Namikawa R, Shih CC, Rabin L, Kaneshima H.

Science. 1990 Feb 2;247(4942):564-6.

PMID:
2300816
37.

Preclinical evaluation of antiviral compounds in the SCID-hu mouse.

McCune JM, Kaneshima H, Rabin L, Shih CC, Namikawa R.

Ann N Y Acad Sci. 1990;616:281-6. Review. No abstract available.

PMID:
2078024
38.

The scid-hu mouse: current status and potential applications.

McCune JM, Kaneshima H, Lieberman M, Weissman IL, Namikawa R.

Curr Top Microbiol Immunol. 1989;152:183-93. Review. No abstract available.

PMID:
2680299
39.

Infection of the SCID-hu mouse by HIV-1.

Namikawa R, Kaneshima H, Lieberman M, Weissman IL, McCune JM.

Science. 1988 Dec 23;242(4886):1684-6.

PMID:
3201256
40.

The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function.

McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL.

Science. 1988 Sep 23;241(4873):1632-9.

PMID:
2971269
41.

Immunohistological analysis of thymic tumors with PE-35 monoclonal antibody reactive with medullary thymic epithelium.

Takahashi T, Ueda R, Nishida K, Namikawa R, Fukami H, Matsuyama M, Masaoka A, Imaizumi M, Takahashi T.

Cancer Res. 1988 Apr 1;48(7):1896-903.

42.
43.

Teratogenic effects of clomiphene, tamoxifen, and diethylstilbestrol on the developing human female genital tract.

Cunha GR, Taguchi O, Namikawa R, Nishizuka Y, Robboy SJ.

Hum Pathol. 1987 Nov;18(11):1132-43.

PMID:
3679188
44.

Clonal T cell population in angioimmunoblastic lymphadenopathy and related lesions.

Suzuki H, Namikawa R, Ueda R, Obata Y, Suchi T, Kikuchi M, Ota K, Takahashi T.

Jpn J Cancer Res. 1987 Jul;78(7):712-20.

PMID:
3114197
45.
46.
47.

Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35.

Takahashi T, Ueda R, Song X, Nishida K, Shinzato M, Namikawa R, Ariyoshi Y, Ota K, Kato K, Nagatsu T, et al.

Cancer Res. 1986 Sep;46(9):4770-5.

48.

Development of multiple organ-localized autoimmune diseases in nude mice after reconstitution of T cell function by rat fetal thymus graft.

Taguchi O, Takahashi T, Seto M, Namikawa R, Matsuyama M, Nishizuka Y.

J Exp Med. 1986 Jul 1;164(1):60-71.

49.

Ontogenic development of T and B cells and non-lymphoid cells in the white pulp of human spleen.

Namikawa R, Mizuno T, Matsuoka H, Fukami H, Ueda R, Itoh G, Matsuyama M, Takahashi T.

Immunology. 1986 Jan;57(1):61-9.

50.

[An autopsy case of primary splenic hemangiosarcoma].

Hasegawa H, Ikeda H, Namikawa R, Baba H, Hananouchi M, Itoh G, Yoshida K, Kojima H.

Gan No Rinsho. 1985 Oct;31(13):1744-9. Japanese.

PMID:
4079065

Supplemental Content

Loading ...
Support Center